CD151 and non-small cell lung carcinoma: CD151 expression has been reported to be associated with advanced cancer stage, cancer invasiveness and poor prognosis in endometrial cancer, hepatocellular carcinoma, breast cancer and non-small cell lung cancer patients [45, 51–55].